Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma

Abstract Background The EANM Research Ltd. (EARL) guidelines give recommendations for harmonization of [18F]FDG PET-CT image acquisition and reconstruction, aiming to ensure reproducibility of quantitative data between PET scanners. Recent technological advancements in PET-CT imaging resulted in an...

Full description

Bibliographic Details
Main Authors: Maurice C. Cox, Tijn Jurcka, Anne I. J. Arens, Maartje C. van Rijk, Johannes H. A. M. Kaanders, Sven van den Bosch
Format: Article
Language:English
Published: SpringerOpen 2023-10-01
Series:EJNMMI Research
Subjects:
Online Access:https://doi.org/10.1186/s13550-023-01042-w
_version_ 1797451534821228544
author Maurice C. Cox
Tijn Jurcka
Anne I. J. Arens
Maartje C. van Rijk
Johannes H. A. M. Kaanders
Sven van den Bosch
author_facet Maurice C. Cox
Tijn Jurcka
Anne I. J. Arens
Maartje C. van Rijk
Johannes H. A. M. Kaanders
Sven van den Bosch
author_sort Maurice C. Cox
collection DOAJ
description Abstract Background The EANM Research Ltd. (EARL) guidelines give recommendations for harmonization of [18F]FDG PET-CT image acquisition and reconstruction, aiming to ensure reproducibility of quantitative data between PET scanners. Recent technological advancements in PET-CT imaging resulted in an updated version of the EARL guidelines (EARL2). The aim of this study is to compare quantitative [18F]FDG uptake metrics of the primary tumor and lymph nodes in patients with head and neck squamous cell carcinoma (HNSCC) on EARL2 versus EARL1 reconstructed images and to describe clinical implications for nodal staging and treatment. Methods Forty-nine consecutive patients with HNSCC were included. For all, both EARL1 and EARL2 images were reconstructed from a singular [18F]FDG PET-CT scan. Primary tumors and non-necrotic lymph nodes ≥ 5 mm were delineated on CT-scan. In the quantitative analysis, maximum standardized uptake values (SUVmax) and standardized uptake ratios (SURmax, i.e., SUVmax normalized to cervical spinal cord uptake) were calculated for all lesions on EARL1 and EARL2 reconstructions. Metabolic tumor volume (MTV) and total lesion glycolysis were compared between EARL1 and EARL2 using different segmentation methods (adaptive threshold; SUV2.5/3.5/4.5; SUR2.5/3.5/4.5; MAX40%/50%). In the qualitative analysis, each lymph node was scored independently by two nuclear medicine physicians on both EARL1 and EARL2 images on different occasions using a 4-point scale. Results There was a significant increase in SUVmax (16.5%) and SURmax (9.6%) of primary tumor and lymph nodes on EARL2 versus EARL1 imaging (p < 0.001). The proportional difference of both SUVmax and SURmax between EARL2 and EARL1 decreased with increasing tumor volume (p < 0.001). Absolute differences in MTVs between both reconstructions were small (< 1.0 cm3), independent of the segmentation method. MTVs decreased on EARL2 using relative threshold methods (adaptive threshold; MAX40%/50%) and increased using static SUV or SUR thresholds. With visual scoring of lymph nodes 38% (11/29) of nodes with score 2 on EARL1 were upstaged to score 3 on EARL2, which resulted in an alteration of nodal stage in 18% (6/33) of the patients. Conclusions Using the EARL2 method for PET image reconstruction resulted in higher SUVmax and SURmax compared to EARL1, with nodal upstaging in a significant number of patients.
first_indexed 2024-03-09T14:55:05Z
format Article
id doaj.art-4b67ed56364949b2aedda30c1d338e88
institution Directory Open Access Journal
issn 2191-219X
language English
last_indexed 2024-03-09T14:55:05Z
publishDate 2023-10-01
publisher SpringerOpen
record_format Article
series EJNMMI Research
spelling doaj.art-4b67ed56364949b2aedda30c1d338e882023-11-26T14:12:30ZengSpringerOpenEJNMMI Research2191-219X2023-10-0113111110.1186/s13550-023-01042-wQuantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinomaMaurice C. Cox0Tijn Jurcka1Anne I. J. Arens2Maartje C. van Rijk3Johannes H. A. M. Kaanders4Sven van den Bosch5Department of Radiation Oncology, Radboud University Medical CenterDepartment of Radiation Oncology, Radboud University Medical CenterDepartment of Radiology and Nuclear Medicine, Radboud University Medical CenterDepartment of Radiology and Nuclear Medicine, Radboud University Medical CenterDepartment of Radiation Oncology, Radboud University Medical CenterDepartment of Radiation Oncology, Radboud University Medical CenterAbstract Background The EANM Research Ltd. (EARL) guidelines give recommendations for harmonization of [18F]FDG PET-CT image acquisition and reconstruction, aiming to ensure reproducibility of quantitative data between PET scanners. Recent technological advancements in PET-CT imaging resulted in an updated version of the EARL guidelines (EARL2). The aim of this study is to compare quantitative [18F]FDG uptake metrics of the primary tumor and lymph nodes in patients with head and neck squamous cell carcinoma (HNSCC) on EARL2 versus EARL1 reconstructed images and to describe clinical implications for nodal staging and treatment. Methods Forty-nine consecutive patients with HNSCC were included. For all, both EARL1 and EARL2 images were reconstructed from a singular [18F]FDG PET-CT scan. Primary tumors and non-necrotic lymph nodes ≥ 5 mm were delineated on CT-scan. In the quantitative analysis, maximum standardized uptake values (SUVmax) and standardized uptake ratios (SURmax, i.e., SUVmax normalized to cervical spinal cord uptake) were calculated for all lesions on EARL1 and EARL2 reconstructions. Metabolic tumor volume (MTV) and total lesion glycolysis were compared between EARL1 and EARL2 using different segmentation methods (adaptive threshold; SUV2.5/3.5/4.5; SUR2.5/3.5/4.5; MAX40%/50%). In the qualitative analysis, each lymph node was scored independently by two nuclear medicine physicians on both EARL1 and EARL2 images on different occasions using a 4-point scale. Results There was a significant increase in SUVmax (16.5%) and SURmax (9.6%) of primary tumor and lymph nodes on EARL2 versus EARL1 imaging (p < 0.001). The proportional difference of both SUVmax and SURmax between EARL2 and EARL1 decreased with increasing tumor volume (p < 0.001). Absolute differences in MTVs between both reconstructions were small (< 1.0 cm3), independent of the segmentation method. MTVs decreased on EARL2 using relative threshold methods (adaptive threshold; MAX40%/50%) and increased using static SUV or SUR thresholds. With visual scoring of lymph nodes 38% (11/29) of nodes with score 2 on EARL1 were upstaged to score 3 on EARL2, which resulted in an alteration of nodal stage in 18% (6/33) of the patients. Conclusions Using the EARL2 method for PET image reconstruction resulted in higher SUVmax and SURmax compared to EARL1, with nodal upstaging in a significant number of patients.https://doi.org/10.1186/s13550-023-01042-wHead and neck cancerPET-CTEARLSUV
spellingShingle Maurice C. Cox
Tijn Jurcka
Anne I. J. Arens
Maartje C. van Rijk
Johannes H. A. M. Kaanders
Sven van den Bosch
Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
EJNMMI Research
Head and neck cancer
PET-CT
EARL
SUV
title Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
title_full Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
title_fullStr Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
title_full_unstemmed Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
title_short Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
title_sort quantitative and clinical implications of the earl2 versus earl1 18f fdg pet ct performance standards in head and neck squamous cell carcinoma
topic Head and neck cancer
PET-CT
EARL
SUV
url https://doi.org/10.1186/s13550-023-01042-w
work_keys_str_mv AT mauriceccox quantitativeandclinicalimplicationsoftheearl2versusearl118ffdgpetctperformancestandardsinheadandnecksquamouscellcarcinoma
AT tijnjurcka quantitativeandclinicalimplicationsoftheearl2versusearl118ffdgpetctperformancestandardsinheadandnecksquamouscellcarcinoma
AT anneijarens quantitativeandclinicalimplicationsoftheearl2versusearl118ffdgpetctperformancestandardsinheadandnecksquamouscellcarcinoma
AT maartjecvanrijk quantitativeandclinicalimplicationsoftheearl2versusearl118ffdgpetctperformancestandardsinheadandnecksquamouscellcarcinoma
AT johanneshamkaanders quantitativeandclinicalimplicationsoftheearl2versusearl118ffdgpetctperformancestandardsinheadandnecksquamouscellcarcinoma
AT svenvandenbosch quantitativeandclinicalimplicationsoftheearl2versusearl118ffdgpetctperformancestandardsinheadandnecksquamouscellcarcinoma